| Abex Pharmaceutica (Pty) Lt |
XITOLEC FC |
None |
470950 |
47/5.7.1/0950 |
2022/01/02 |
Registered
|
info |
| Abex Pharmaceutica (Pty) Lt |
XEVOLCIN FC |
None |
470951 |
47/5.7.1/0951 |
2022/01/02 |
Registered
|
info |
| Accord Healthcare (Pty) Ltd |
XARTIGEN 5 |
None |
500649 |
50/7.5/0649 |
2021/08/06 |
Registered
|
info |
| Accord Healthcare (Pty) Ltd |
XARTIGEN 10 |
None |
500650 |
50/7.5/0650 |
2021/08/06 |
Registered
|
info |
| Accord Healthcare (Pty) Ltd |
XARTIGEN 20 |
None |
500651 |
50/7.5/0651 |
2021/08/06 |
Registered
|
info |
| Accord Healthcare (Pty) Ltd |
XARTIGEN 40 |
None |
500652 |
50/7.5/0652 |
2021/08/06 |
Registered
|
info |
| Accord Healthcare (Pty) Ltd |
XEMASIN 25 |
None |
471119 |
47/21.12/1119 |
2021/06/22 |
Registered
|
info |
| Activo Health (Pty) Ltd |
XABARO 2,5 |
None |
520898 |
52/8.2/0898 |
2022/04/19 |
Registered
|
info |
| Activo Health (Pty) Ltd |
XABARO 10 |
None |
520899 |
52/8.2/0899 |
2022/04/19 |
Registered
|
info |
| Activo Health (Pty) Ltd |
XABARO 15 |
None |
520900 |
52/8.2/0900 |
2022/04/19 |
Registered
|
info |
| Activo Health (Pty) Ltd |
XABARO 20 |
None |
520901 |
52/8.2/0901 |
2022/04/19 |
Registered
|
info |
| Adcock Ingram Limited |
XYLOTOX 2 % PLAIN S.E. |
EACH ML CONTAINS
LIDOCAINE HYDROCHLORIDE A = ANHYDROUS 20 MG |
G2803 |
Old Medicine |
1974/01/12 |
Registered
|
info |
| Adcock Ingram Limited |
XYLOTOX L |
EACH ml OF SOLUTION CONTAINS
LIDOCAINE HYDROCHLORIDE A 20 mg
NOREPINEPHRINE A 12,5 mcg |
G2798 |
Old Medicine |
1974/01/12 |
Registered
|
info |
| Adcock Ingram Limited |
XYLOTOX S.E. PLAIN |
EACH 2,0 ml SOLUTION CONTAINS
LIDOCAINE HYDROCHLORIDE A 40,0 mg |
G2799 |
Old Medicine |
1974/01/12 |
Registered
|
info |
| Adcock Ingram Limited |
XENOGEX |
EACH TABLET CONTAINS
LEVOCETIRIZINE DIHYDROCHLORIDE 5,0 mg |
460299 |
46/5.7.1/0299 |
2018/11/06 |
#N/A
|
info |
| Adcock Ingram Limited |
XYLOTOX E80-A |
EACH 1 ml SOLUTION CONTAINS
ADRENALINE 12,5 ug
LIDOCAINE HYDROCHLORIDE 20 mg |
P0170 |
P/4/170 |
1982/02/07 |
Registered
|
info |
| Adcock Ingram Limited |
XAMIOL GEL |
EACH 1,0 g GEL CONTAINS
BETAMETHASONE DIPROPIONATE EQUIVALENT TO BETAMETHASONE 0,5 mg
CALCIPOTRIOL 50,0 ug |
440632 |
44/13.9.1/0632 |
2012/04/20 |
Registered
|
info |
| Adcock Ingram Critical Care (Pty) Ltd |
XATIZA |
EACH 1,5 ML SOLUTION CONTAINS
CABAZITAXEL 60,0 mg |
530361.36 |
53/26/0361.360 |
2020/01/12 |
Registered
|
info |
| Adcock Ingram Critical Care (Pty) Ltd |
XITACAB |
EACH 1,5 ML SOLUTION CONTAINS
CABAZITAXEL 60,0 mg |
530362.36 |
53/26/0362.360 |
2020/01/12 |
Registered
|
info |
| African Medicines (Pty) Ltd trading as Pakmed Self Medication |
X.M. TABLETS |
EACH TABLET CONTAINS
DRIED YEAST A 5,0 MG
PRECIPITATED SULFUR A 20,0 MG |
G2614 |
Old Medicine |
1974/06/12 |
Registered
|
info |
| ALKEM LABORATORIES (PTY) LTD |
XIROV 5 |
None |
540506 |
54/1.2/0506 |
2022/05/31 |
Registered
|
info |
| ALKEM LABORATORIES (PTY) LTD |
XIROV 10 |
None |
540507 |
54/1.2/0507 |
2022/05/31 |
Registered
|
info |
| ALKEM LABORATORIES (PTY) LTD |
XIROV 15 |
None |
540508 |
54/1.2/0508 |
2022/05/31 |
Registered
|
info |
| ALKEM LABORATORIES (PTY) LTD |
XIROV 20 |
None |
540509 |
54/1.2/0509 |
2022/05/31 |
Registered
|
info |
| Astellas Pharma (Pty) Ltd |
XTANDI 40 mg |
EACH CAPSULE CONTAINS
ENZALUTAMIDE 40,0 mg |
480404 |
48/26/0404 |
2016/09/30 |
Registered
|
info |
| AstraZeneca Pharmaceuticals (Pty) Ltd- Bryanston |
XYLOCAINE 10 mg/0,1 ml |
EACH DOSE CONTAINS
LIDOCAINE A 10 mg |
G2826 |
Old Medicine |
1974/01/12 |
Registered
|
info |
| AstraZeneca Pharmaceuticals (Pty) Ltd- Bryanston |
XIGDUO XR 10 mg/ 500 mg |
None |
520412 |
52/21.2/0412 |
2021/04/20 |
Registered
|
info |
| AstraZeneca Pharmaceuticals (Pty) Ltd- Bryanston |
XIGDUO XR 10 mg/ 1000 mg |
None |
520413 |
52/21.2/0413 |
2021/04/20 |
Registered
|
info |
| AstraZeneca Pharmaceuticals (Pty) Ltd- Bryanston |
XIGDUO XR 5 mg/ 500 mg |
None |
520414 |
52/21.2/0414 |
2021/04/20 |
Registered
|
info |
| AstraZeneca Pharmaceuticals (Pty) Ltd- Bryanston |
XIGDUO XR 5 mg/ 1000 mg |
None |
520415 |
52/21.2/0415 |
2021/04/20 |
Registered
|
info |
| Aurogen South Africa (Pty) Ltd |
XYCILAN SUSPENSION 125 mg/5 ml |
EACH 5,0 ml SUSPENSION CONTAINS
AMOXYCILLIN TRIHYDRATE EQUIVALENT TO AMOXYCILLIN 125,0 mg |
420335 |
42/20.1.2/0335 |
2017/12/12 |
#N/A
|
info |
| Aurogen South Africa (Pty) Ltd |
XYCILAN SUSPENSION 250 mg/5 ml |
EACH 5,0 ml SUSPENSION CONTAINS
AMOXYCILLIN TRIHYDRATE EQUIVALENT TO AMOXYCILLIN 250,0 mg |
420336 |
42/20.1.2/0336 |
2017/12/12 |
#N/A
|
info |
| Aurogen South Africa (Pty) Ltd |
XIPANZ 0,25 mg, |
None |
480705 |
48/2.6/0705 |
2021/10/08 |
Registered
|
info |
| Aurogen South Africa (Pty) Ltd |
XIPANZ 0,5 mg |
None |
480706 |
48/2.6/0706 |
2021/10/08 |
Registered
|
info |
| Aurogen South Africa (Pty) Ltd |
XIPANZ 1 mg |
None |
480707 |
48/2.6/0707 |
2021/10/08 |
Registered
|
info |
| Aurogen South Africa (Pty) Ltd |
XIPANZ XR 0,5 mg |
None |
500094 |
50/2.6/0094 |
2021/09/14 |
Registered
|
info |
| Aurogen South Africa (Pty) Ltd |
XIPANZ XR 1 mg |
None |
500095 |
50/2.6/0095 |
2021/09/14 |
Registered
|
info |
| Aurogen South Africa (Pty) Ltd |
XIPANZ XR 2 mg |
None |
500096 |
50/2.6/0096 |
2021/09/14 |
Registered
|
info |
| Aurogen South Africa (Pty) Ltd |
XIPANZ XR 3 mg |
None |
500097 |
50/2.6/0097 |
2021/09/14 |
Registered
|
info |
| Aurogen South Africa (Pty) Ltd |
XENARA ORAL SUSPENSION 125 mg/5 ml |
None |
550158.156 |
55/20.1.1/0158.156 |
2022/06/28 |
Registered
|
info |
| Aurogen South Africa (Pty) Ltd |
XENARA ORAL SUSPENSION 250 mg/5 ml |
None |
550159.157 |
55/20.1.1/0159.157 |
2022/06/28 |
Registered
|
info |
| Austell Pharmaceuticals (Pty) Ltd |
XEOMIN 50 UNITS |
EACH VIAL CONTAINS
BOTULINUM NEUROTOXIN TYPE 50,0 UNITS |
530223 |
53/30.5/0223 |
2021/01/21 |
Registered
|
info |
| Austell Pharmaceuticals (Pty) Ltd |
XEOMIN 100 UNITS |
EACH VIAL CONTAINS
BOTULINUM NEUROTOXIN TYPE 100,0 UNITS |
530224 |
53/30.5/0224 |
2021/01/21 |
Registered
|
info |
| Austell Pharmaceuticals (Pty) Ltd |
XOBREST 20 mg/ 1 mL |
None |
510273 |
51/26/0273 |
2021/06/04 |
Registered
|
info |
| Austell Pharmaceuticals (Pty) Ltd |
XOBREST 80 mg/ 4 mL |
None |
510274 |
51/26/0274 |
2021/06/04 |
Registered
|
info |
| Austell Pharmaceuticals (Pty) Ltd |
XOBREST 140 mg/ 7 mL |
None |
510275 |
51/26/0275 |
2021/06/04 |
Registered
|
info |
| Austell Pharmaceuticals (Pty) Ltd |
XINOCLOC 250 |
EACH CAPSULE CONTAINS
FLUCLOXACILLIN SODIUM EQUIVALENT TO FLUCLOXACILLIN 250,0 mg |
550222 |
55/20.1.2/0222 |
2021/06/07 |
#N/A
|
info |
| Baroque Pharmaceuticals (Pty) Ltd |
XIENCE V |
EACH STENT CONTAINS
EVEROLIMUS 100,0 ug/cm |
420699 |
42/34/0699 |
2010/04/30 |
#N/A
|
info |
| Bayer (Pty) Ltd û Isando |
XARELTO 10 |
EACH TABLET CONTAINS
RIVAROXABAN 10,0 mg |
421046 |
42/8.2/1046 |
2010/01/27 |
Registered
|
info |
| Bayer (Pty) Ltd û Isando |
XOFIGO |
EACH 1,0 ml SOLUTION CONTAINS
RADIUM-224 0,53 ng |
480715 |
48/32.15/0715 |
2016/02/18 |
#N/A
|
info |
| Bayer (Pty) Ltd û Isando |
XARELTO 15 |
EACH TABLET CONTAINS
RIVAROXABAN 15,0 mg |
460111 |
46/8.2/0111 |
2013/05/12 |
#N/A
|
info |
| Bayer (Pty) Ltd û Isando |
XARELTO 20 |
EACH TABLET CONTAINS
RIVAROXABAN 20,0 mg |
460112 |
46/8.2/0112 |
2013/05/12 |
#N/A
|
info |
| Bayer (Pty) Ltd û Isando |
XARELTO 2.5 mg |
None |
470137 |
47/8.2/0137 |
2020/08/18 |
Registered
|
info |
| Dr ReddyÆs Laboratories (Pty) Ltd |
XOPHANU 5 mg |
None |
480041 |
48/2.6.5/0041 |
2021/02/23 |
Registered
|
info |
| Dr ReddyÆs Laboratories (Pty) Ltd |
XOPHANU 10 mg |
None |
480042 |
48/2.6.5/0042 |
2021/02/23 |
Registered
|
info |
| Dr ReddyÆs Laboratories (Pty) Ltd |
XOPHANU 15 mg |
None |
480043 |
48/2.6.5/0043 |
2021/02/23 |
Registered
|
info |
| Eden Pharma SA (Pty) Ltd |
X/5.2/389 |
EACH TABLET CONTAINS
ATENOLOL 100 mg |
X0389 |
X/5.2/389 |
1991/01/23 |
Registered
|
info |
| Equity Pharmaceutical (Pty) Ltd |
XIFAXAN |
None |
510036 |
51/20.1.1/0036 |
2020/07/14 |
Registered
|
info |
| ER BERNARD PHARMACEUTICALS (PTY) LTD |
XYLONOR SPRAY |
EACH 100 G CONTAINS
LIDOCAINE A 15,0 G |
G2822 |
Old Medicine |
1974/05/12 |
Registered
|
info |
| FDC SA (Pty) Ltd |
XERAZOLE SUSPENSION |
EACH 5,0 ml SUSPENSION CONTAINS
SULFAMETHOXAZOLE 200,0 mg
TRIMETHOPRIM 40,0 mg |
280389 |
28/20.2/0389 |
1994/11/14 |
#N/A
|
info |
| FDC SA (Pty) Ltd |
XERASPOR T CREAM |
EACH 100,0 g CREAM CONTAINS
CLOTRIMAZOLE 1,0 g |
280390 |
28/20.2.2/0390 |
1995/02/23 |
#N/A
|
info |
| FDC SA (Pty) Ltd |
XERASPOR V CREAM |
EACH 100,0 g CREAM CONTAINS
CLOTRIMAZOLE 1,0 g |
280391 |
28/20.2.2/0391 |
1995/02/23 |
#N/A
|
info |
| FDC SA (Pty) Ltd |
XERAMEL 250 |
EACH CAPSULE CONTAINS
ERYTHROMYCIN ESTOLATE EQUIVALENT TO ETYTHROMYCIN 250,0 mg |
280386 |
28/20.1.1/0386 |
1996/09/01 |
#N/A
|
info |
| FDC SA (Pty) Ltd |
XERAMEL S |
EACH 5 ml CONTAINS
ERYTHROMYCIN ESTOLATE EQUIVALENT TO ERYTHROMYCIN 125 mg |
280387 |
28/20.1.1/0387 |
1996/09/01 |
#N/A
|
info |
| FDC SA (Pty) Ltd |
XERAMEL SF |
EACH 5,0 ml SUSPENSION CONTAINS
ERYTHROMYCIN ESTOLATE EQUIVALENT TO ERYTHROMYCIN 250,0 mg |
280388 |
28/20.1.1/0388 |
1998/05/27 |
#N/A
|
info |
| Forrester Pharma (Pty) Ltd |
XBIRA |
None |
520340 |
52/21.12/0340 |
2020/02/06 |
Registered
|
info |
| GAREC (PTY) LTD |
XANOLAM 0,5 mg |
EACH TABLET CONTAINS
ALPRAZOLAM 0,5 mg |
310015 |
31/2.6/0015 |
1998/12/05 |
#N/A
|
info |
| Gen-Eye (Pty) Ltd |
XINOCT |
EACH 1,0 ml SOLUTION CONTAINS
CIPROFLOXACIN HYDROCHLORIDE EQUIVALENT TO CIPROFLOXACCIN 3,5 mg |
470959 |
47/15.1/0959 |
2019/06/26 |
Registered
|
info |
| GlaxoSmithKline South Africa (Pty) Limited |
XYZAL ORAL SOLUTION |
EACH 1,0 ml SOLUTION CONTAINS
LEVOCETIRIZINE DIHYDROCHLORIDE 0,50 mg |
410032 |
41/5.7.1/0032 |
2010/01/27 |
Registered
|
info |
| GlaxoSmithKline South Africa (Pty) Limited |
XYZAL |
EACH TABLET CONTAINS
LEVOCETIRIZINE DIHYDROCHLORIDE 5,0 mg |
360425 |
36/5.7.1/0425 |
2004/05/28 |
#N/A
|
info |
| Glenmark Pharmaceuticals South Africa (Pty) Ltd |
XUBATEL 20 mg |
None |
520520 |
52/26/0520 |
2021/07/20 |
Registered
|
info |
| Glenmark Pharmaceuticals South Africa (Pty) Ltd |
XUBATEL 80 mg |
None |
520521 |
52/26/0521 |
2021/07/20 |
Registered
|
info |
| Guerbet South Africa (Pty) Ltd |
XENETIX 250 |
EACH 1,0 ml SOLUTION CONTAINS
IOBITRIDOL EQUIVALENT TO 250,0 mg IODINE |
310552 |
31/28/0552 |
1997/01/09 |
#N/A
|
info |
| Guerbet South Africa (Pty) Ltd |
XENETIX 300 |
EACH 1,0 ml SOLUTION CONTAINS
IOBITRIDOL EQUIVALENT TO 300,0 mg IODINE |
310553 |
31/28/0553 |
1997/01/09 |
#N/A
|
info |
| Guerbet South Africa (Pty) Ltd |
XENETIX 350 |
EACH 1,0 ml SOLUTION CONTAINS
IOBITRIDOL EQUIVALENT T0 350,0 mg IODINE |
310554 |
31/28/0554 |
1997/01/09 |
#N/A
|
info |
| Intervet South Africa (Pty) Ltd |
XYLAVET 2 % |
EACH 1,0 ml SOLUTION CONTAINS
XYLAZINE 20,0 mg |
00/8 |
00/2.2/8 |
2003/07/03 |
Registered
|
info |
| Intervet South Africa (Pty) Ltd |
XYLAVET 10 % FOR HORSES |
EACH 1,0 ml SOLUTION CONTAINS
XYLAZINE 100,0 mg |
00/9 |
00/2.2/9 |
2003/07/03 |
Registered
|
info |
| Janssen Pharmaceutica (Pty) Ltd |
XEPLION 25 mg/0,25 ml |
EACH PRE-FILLED SYRINGE CONTAINS
PALIPERIDONE 25,0 mg |
440865 |
44/2.6.5/0865 |
2013/01/03 |
#N/A
|
info |
| Janssen Pharmaceutica (Pty) Ltd |
XEPLION 50 mg/0,50 ml |
EACH PRE-FILLED SYRINGE CONTAINS
PALIPERIDONE 50,0 mg |
440866 |
44/2.6.5/0866 |
2013/01/03 |
#N/A
|
info |
| Janssen Pharmaceutica (Pty) Ltd |
XEPLION 75 mg/0,75 ml |
EACH PRE-FILLED SYRINGE CONTAINS
PALIPERIDONE 75,0 mg |
440867 |
44/2.6.5/0867 |
2013/01/03 |
#N/A
|
info |
| Janssen Pharmaceutica (Pty) Ltd |
XEPLION 100 mg/1,0 ml |
EACH PRE-FILLED SYRINGE CONTAINS
PALIPERIDONE 100,0 mg |
440868 |
44/2.6.5/0868 |
2013/01/03 |
#N/A
|
info |
| Janssen Pharmaceutica (Pty) Ltd |
XEPLION 150 mg/1,50 ml |
EACH PRE-FILLED SYRINGE CONTAINS
PALIPERIDONE 150,0 mg |
440870 |
44/2.6.5/0870 |
2013/01/03 |
#N/A
|
info |
| LITHA PHARMA (PTY) LTD |
XEFO 4 |
EACH TABLET CONTAINS
LORNOXICAM 4,0 mg |
330247 |
33/3.1/0247 |
1999/10/29 |
#N/A
|
info |
| LITHA PHARMA (PTY) LTD |
XEFO 8 |
EACH TABLET CONTAINS
LORNOXICAM 8,0 mg |
330248 |
33/3.1/0248 |
1999/10/29 |
#N/A
|
info |
| LITHA PHARMA (PTY) LTD |
XEFO 8 IV/IM |
EACH VIAL CONTAINS
LORNOXICAM 8,0 mg |
330249 |
33/3.1/0249 |
1999/10/29 |
#N/A
|
info |
| LITHA PHARMA (PTY) LTD |
XEFO WATER FOR INJECTION |
EACH AMPOULE CONTAINS
WATER FOR INJECTIONS 2,0 ml |
330250 |
33/34/0250 |
1999/10/29 |
#N/A
|
info |
| LITHA PHARMA (PTY) LTD |
XEFO RAPID |
EACH TABLET CONTAINS
LORNOXICAM 8,0 mg |
440331 |
44/3.1/0331 |
2012/09/14 |
#N/A
|
info |
| Macleods Pharmaceuticals SA (Pty) Ltd |
XETSIA DR 30 mg |
None |
510933 |
51/1.2/0933 |
2020/07/28 |
Registered
|
info |
| Macleods Pharmaceuticals SA (Pty) Ltd |
XETSIA DR 60 mg |
None |
510934 |
51/1.2/0934 |
2020/07/28 |
Registered
|
info |
| Merck (Pty) Ltd |
XIXIA-CLOMIPRAMINE HYDROCHLORIDE 25 |
EACH TABLET CONTAINS
CLOMIPRAMINE HYDROCHLORIDE 25,O mg |
320177 |
32/1.2/0177 |
2000/04/18 |
#N/A
|
info |
| Mylan Pharmaceuticals (Pty) Ltd |
XETHERA 10 mg |
None |
510988 |
51/1.2/0988 |
2021/09/14 |
Registered
|
info |
| Mylan Pharmaceuticals (Pty) Ltd |
XETHERA 18 mg |
None |
510989 |
51/1.2/0989 |
2021/09/14 |
Registered
|
info |
| Mylan Pharmaceuticals (Pty) Ltd |
XETHERA 25 mg |
None |
510990 |
51/1.2/0990 |
2021/09/14 |
Registered
|
info |
| Mylan Pharmaceuticals (Pty) Ltd |
XETHERA 40 mg |
None |
510991 |
51/1.2/0991 |
2021/09/14 |
Registered
|
info |
| Mylan Pharmaceuticals (Pty) Ltd |
XETHERA 60 mg |
None |
510992 |
51/1.2/0992 |
2021/09/14 |
Registered
|
info |
| Mylan Pharmaceuticals (Pty) Ltd |
XETHERA 80 mg |
None |
510993 |
51/1.2/0993 |
2021/09/14 |
Registered
|
info |
| Novartis South Africa (Pty) Ltd |
XOLAIR 75 mg/0,5 ml |
EACH 0,5 ml SOLUTION CONTAINS
OMALIZUMAB 75,0 mg |
550713 |
55/34/0713 |
2021/05/25 |
#N/A
|
info |
| Novartis South Africa (Pty) Ltd |
XOLAIR 150 mg/1,0 ml |
EACH 1,0 ml SOLUTION CONTAINS
OMALIZUMAB 150,0 mg |
550714 |
55/34/0714 |
2021/05/25 |
#N/A
|
info |
| Novartis South Africa (Pty) Ltd |
XOLAIR 75 mg |
EACH VIAL CONTAINS
OMALIZUMAB 75,0 mg |
A390310 |
A39/34/0310 |
2008/09/12 |
Canceled
|
info |
| Novartis South Africa (Pty) Ltd |
XOLAIR 150 mg |
EACH VIAL CONTAINS
OMALIZUMAB 150,0 mg |
A390311 |
A39/34/0311 |
2008/09/12 |
Registered
|
info |
| Novo Nordisk (Pty) Ltd û (Rivonia) |
XULTOPHY |
EACH 1,0 ml SOLUTION CONTAINS
INSULIN DEGLUDEC 100,0 IU
LIRAGLUTIDE 3,6 mg |
500985 |
50/21.13/0985 |
2019/09/12 |
Registered
|
info |
| Oethmaan Biosims (Pty) Ltd |
XEROPRIM |
EACH TABLET CONTAINS
SULFAMETHOXAZOLE 400 mg
TRIMETHOPRIM 80 mg |
270077 |
27/20.2/0077 |
1992/08/18 |
#N/A
|
info |
| Pfizer Laboratories (Pty) Ltd |
XALKORI 200 mg |
EACH CAPSULE CONTAINS
CRIZOTINIB 200,0 mg |
470568 |
47/26/0568 |
2018/03/20 |
#N/A
|
info |
| Pfizer Laboratories (Pty) Ltd |
XALKORI 250 mg |
EACH CAPSULE CONTAINS
CRIZOTINIB 250,0 mg |
470569 |
47/26/0569 |
2018/03/20 |
#N/A
|
info |
| Pfizer Laboratories (Pty) Ltd |
XELJANZ 5mg |
None |
471156 |
47/3.1/1156 |
2020/10/27 |
Registered
|
info |
| Pfizer Laboratories (Pty) Ltd |
XELJANZ 10mg |
None |
471157 |
47/3.1/1157 |
2020/10/27 |
Registered
|
info |
| Pfizer Laboratories (Pty) Ltd |
XYNTHA 500 I.U. |
EACH 10,0 ml VIAL CONTAINS
MOROCTOCOG ALFA 500,0 iu |
350067 |
35/8.1/0067 |
2005/11/02 |
#N/A
|
info |
| Pfizer Laboratories (Pty) Ltd |
XYNTHA 1 000 I.U. |
EACH 10,0 ml VIAL CONTAINS
MOROCTOCOG ALFA 1000,0 iu |
350068 |
35/8.1/0068 |
2005/11/02 |
#N/A
|
info |
| Pharmacare Limited û Woodmead |
XYCAM - 20 |
EACH CAPSULE CONTAINS
PIROXICAM 20 mg |
V0250 |
V/3.1/250 |
1990/02/13 |
Registered
|
info |
| Pharmacare Limited û Woodmead |
XYCAM DISPERSIBLE TABLETS |
EACH TABLET CONTAINS
PIROXICAM 20 mg |
Y0227 |
Y/3.1/227 |
1991/06/14 |
Registered
|
info |
| Pharmacare Limited û Woodmead |
XYCAM SUPPOSITORIES |
EACH SUPPOSITORY CONTAINS
PIROXICAM 20 mg |
270159 |
27/3.1/0159 |
1994/07/22 |
#N/A
|
info |
| Pharmacare Limited û Woodmead |
XENOVATE OINTMENT |
EACH 5 g OINTMENT CONTAINS
CLOBETASOL PROPIONATE 0,0025 g |
280611 |
28/13.4.1/0611 |
1995/01/19 |
#N/A
|
info |
| Pharmacare Limited û Woodmead |
XENOVATE CREAM |
EACH 5 g CREAM CONTAINS
CLOBETASOL PROPIONATE 0,0025 g |
280728 |
28/13.4.1/0728 |
1995/11/27 |
Registered
|
info |
| Pharmaco Distribution (Pty) Ltd |
XENICAL |
EACH CAPSULE CONTAINS
ORLISTAT 120,0 mg |
320475 |
32/11.3.1/0475 |
1999/06/21 |
Registered
|
info |
| Pharma-Q Holdings (Pty) Ltd |
XERAZOLE TABLETS |
EACH TABLET CONTAINS
SULFAMETHOXAZOLE 400 mg
TRIMETHOPRIM 80 mg |
280584 |
28/20.2/0584 |
1995/11/21 |
#N/A
|
info |
| Roche Products (Pty) Ltd |
XOFLUZA 20 mg |
EACH TABLET CONTAINS
BALOXAVIR MARBOXIL 20,0 mg |
550333 |
55/20.2.8/0333 |
2021/09/02 |
#N/A
|
info |
| Roche Products (Pty) Ltd |
XOFLUZA 40 mg |
None |
550334 |
55/20.2.8/0344 |
2021/09/02 |
Registered
|
info |
| Roche Products (Pty) Ltd |
XELODA 150 |
EACH TABLET CONTAINS
CAPECITABINE 150,0 mg |
330198 |
33/26/0198 |
2000/07/31 |
#N/A
|
info |
| Roche Products (Pty) Ltd |
XELODA 500 |
EACH TABLET CONTAINS
CAPECITABINE 500,0 mg |
330199 |
33/26/0199 |
2000/08/24 |
Registered
|
info |
| Sanofi-Aventis South Africa (Pty) Ltd |
XATRAL XL 10 mg |
EACH TABLET CONTAINS
ALFUZOSIN 10,0 mg |
350074 |
35/5.2/0074 |
2003/05/09 |
#N/A
|
info |
| Trinity Pharma (Pty) Ltd |
XALIPMIN 10 |
None |
490477 |
49/7.5/0477 |
2021/03/16 |
Registered
|
info |
| Trinity Pharma (Pty) Ltd |
XALIPMIN 20 |
None |
490478 |
49/7.5/0478 |
2021/03/16 |
Registered
|
info |
| Trinity Pharma (Pty) Ltd |
XALIPMIN 40 |
None |
490479 |
49/7.5/0479 |
2021/03/16 |
Registered
|
info |
| Trinity Pharma (Pty) Ltd |
XALIPMIN 80 |
None |
490480 |
49/7.5/0480 |
2021/03/16 |
Registered
|
info |
| Trinity Pharma (Pty) Ltd |
XYVILIN 50 |
None |
521016 |
52/21.2/1016 |
2021/07/27 |
Registered
|
info |
| UNIVERSAL PHARMACEUTICALS (PTY) LTD |
XPELPYN |
TABLET
CODEINE PHOSPHATE A 8 MG
PARACETAMOL A 500 MG |
B0843 |
Old Medicine |
1969/02/12 |
Registered
|
info |
| Viatris Healthcare (Pty) Ltd |
XANOR 0,25 mg |
EACH TABLET CONTAINS
ALPRAZOLAM 0,25 mg |
M0233 |
M/2.6/233 |
1983/05/23 |
Registered
|
info |
| Viatris Healthcare (Pty) Ltd |
XANOR 0,5 mg |
EACH TABLET CONTAINS
ALPRAZOLAM 0,5 mg |
M0234 |
M/2.6/234 |
1983/05/23 |
Registered
|
info |
| Viatris Healthcare (Pty) Ltd |
XANOR 1 mg |
EACH TABLET CONTAINS
ALPRAZOLAM 1,0 mg |
M0235 |
M/2.6/235 |
1983/05/23 |
Registered
|
info |
| Viatris Healthcare (Pty) Ltd |
XANOR 2,0 mg |
EACH TABLET CONTAINS
ALPRAZOLAM 2,0 mg |
270096 |
27/2.6/0096 |
1993/10/20 |
#N/A
|
info |
| Viatris Healthcare (Pty) Ltd |
XANOR SR 0,5 mg |
EACH TABLET CONTAINS
ALPRAZOLAM 0,50 mg |
290504 |
29/2.6/0504 |
1996/06/21 |
#N/A
|
info |
| Viatris Healthcare (Pty) Ltd |
XANOR SR 1,0 mg |
EACH TABLET CONTAINS
ALPRAZOLAM 1 mg |
290505 |
29/2.6/0505 |
1996/06/21 |
#N/A
|
info |
| Viatris Healthcare (Pty) Ltd |
XANOR SR 2,0 mg |
EACH TABLET CONTAINS
ALPRAZOLAM 2 mg |
290506 |
29/2.6/0506 |
1996/06/21 |
#N/A
|
info |
| Upjohn South Africa (Pty) Ltd |
XALATAN |
EACH 1 ml EYE DROPS CONTAINS
LATANOPROST 50 ug |
310614 |
31/15.4/0614 |
1997/09/25 |
#N/A
|
info |
| Viatris Healthcare (Pty) Ltd |
XALACOM |
EACH 1,0 ml SOLUTION CONTAINS
LATANOPROST 50,0 ug
TIMOLOL MALEATE EQUIVALENT TO TIMOLOL 5,0 mg |
360043 |
36/15.4/0043 |
2002/11/15 |
#N/A
|
info |
| XERAGEN LABORATORIES (PTY) LTD |
XERACIL S |
EACH 5 ML SUSPENSION CONTAINS
AMOXYCILLIN TRIHYDRATE 157,82 MG EQUIVALENT TO AMOXYCILLIN 125 MG |
280394 |
28/20.1.2/0394 |
1995/02/23 |
#N/A
|
info |
| XERAGEN LABORATORIES (PTY) LTD |
XERACIL SF |
EACH 5 ML SUSPENSION CONTAINS
AMOXYCILLIN TRIHYDRATE 315,64 MG EQUIVALENT TO AMOXYCILLIN 250 MG |
280395 |
28/20.1.2/0395 |
1995/04/19 |
#N/A
|
info |
| XERAGEN LABORATORIES (PTY) LTD |
XERACIL 500* |
EACH CAPSULE CONTAINS
AMOXYCILLIN TRIHYDRATE EQUIVALENT TO 500 mg AMOXYCILLIN |
280393 |
28/20.1.2/0393 |
1995/10/11 |
#N/A
|
info |
| XERAGEN LABORATORIES (PTY) LTD |
XERACIL 250 |
EACH CAPSULE CONTAINS
AMOXYCILLIN TRIHYDRATE 301,3 MG EQUIVALENT TO AMOXYCILLIN 250 MG |
280392 |
28/20.1.2/0392 |
1995/11/14 |
#N/A
|
info |
| XIXIA PHARMACEUTICALS (PTY) LTD |
XIXIA-BICALUTAMIDE 50 |
EACH TABLET CONTAINS
BICALUTAMIDE 50,0 mg |
410745 |
41/21.12/0745 |
2012/02/03 |
#N/A
|
info |
| XIXIA PHARMACEUTICALS (PTY) LTD |
XIXIA INDOMETHACIN CAPSULES* |
EACH CAPSULE CONTAINS
INDOMETHACIN 25 mg |
280020 |
28/3.1/0020 |
1995/03/31 |
#N/A
|
info |
| XIXIA PHARMACEUTICALS (PTY) LTD |
XIXIA NITROFURAZONE OINTMENT |
100 G
NITROFURAZONE 200 MG |
290549 |
29/14.1/0549 |
1996/01/31 |
#N/A
|
info |
| XIXIA PHARMACEUTICALS (PTY) LTD |
XIAPEN 250 |
CAPSULE |
280659 |
28/20.1.2/0659 |
1996/05/06 |
#N/A
|
info |
| XIXIA PHARMACEUTICALS (PTY) LTD |
XIAPEN S |
5 ML
AMPICILLIN TRIHYDRATE 147,95 MG |
290153 |
29/20.1.2/0153 |
1996/06/21 |
#N/A
|
info |
| XIXIA PHARMACEUTICALS (PTY) LTD |
XIXIA HALOFANTRINE TABLETS |
EACH TABLET CONTAINS
HALOFANTRINE HYDROCHLORIDE 250 mg |
290546 |
29/20.2.6/0546 |
1996/03/09 |
#N/A
|
info |
| XIXIA PHARMACEUTICALS (PTY) LTD |
XIXIA HALOFANTRINE SUSPENSION |
EACH 5 ml SUSPENSION CONTAINS
HALOFANTRINE HYDROCHLORIDE 100 mg |
290547 |
29/20.2.6/0547 |
1996/03/09 |
#N/A
|
info |
| XIXIA PHARMACEUTICALS (PTY) LTD |
XIXIA CLOXACILLIN CAPSULES 500 mg |
EACH CAPSULE CONTAINS
CLOXACILLIN SODIUM 545,95 MG EQUIVALENT TO 500 MG CLOXACILLIN |
290544 |
29/20.1.2/0544 |
1996/12/09 |
#N/A
|
info |
| XIXIA PHARMACEUTICALS (PTY) LTD |
XIAPEN 500 |
EACH CAPSULE CONTAINS
AMPICILLIN TRIHYDRATE 577,4 mg EQUIVALENT TO 500 mg AMPICILLIN |
280660 |
28/20.1.1/0660 |
1996/11/14 |
#N/A
|
info |
| XIXIA PHARMACEUTICALS (PTY) LTD |
XIXIA GRANISETRON INJECTION |
EACH 3 ml SOLUTION CONTAINS
GRANISETRON HYDROCHLORIDE EQUIVALENT TO 3,0 mg GRANISETRON |
290545 |
29/5.7.2/0545 |
1997/09/01 |
#N/A
|
info |
| XIXIA PHARMACEUTICALS (PTY) LTD |
XIAPEN SF |
EACH 5 ml SUSPENSION CONTAINS
AMPICILLIN TRIHYDRATE 295,89 mg EQUIVALENT TO 250 mg AMPICILLIN |
290154 |
29/20.1.2/0154 |
1997/01/16 |
#N/A
|
info |
| XIXIA PHARMACEUTICALS (PTY) LTD |
XIXIA NITROFURAZONE CREAM |
EACH 100 g CREAM CONTAINS
NITROFURAZONE 200 mg |
290548 |
29/14.1/0548 |
1999/08/02 |
#N/A
|
info |
| XIXIA PHARMACEUTICALS (PTY) LTD |
XIXIA-FLUCLOXACILLIN S |
EACH 5,0 ml SUSPENSION CONTAINS
FLUCLOXACILLIN SODIUM EQUIVALENT TO FLUCLOXACILLIN 125,0 mg |
290551 |
29/20.1.2/0551 |
1999/08/02 |
#N/A
|
info |
| XIXIA PHARMACEUTICALS (PTY) LTD |
XIXIA CLOXACILLIN INJECTION 500 mg |
EACH VIAL CONTAINS
CLOXACILLIN SODIUM EQUIVALENT TO CLOXACILLIN 500,0 mg |
290543 |
29/20.1.2/0543 |
1999/03/06 |
#N/A
|
info |
| XIXIA PHARMACEUTICALS (PTY) LTD |
XIXIA PAROXETINE 20 |
EACH TABLET CONTAINS
PAROXETINE HYDROCHLORIDE EQUIVALENT TO PAROXETINE 20,0 mg |
290556 |
29/1.2/0556 |
2000/05/29 |
#N/A
|
info |
| XIXIA PHARMACEUTICALS (PTY) LTD |
XIXIA-CLARITHROMYCIN 250 mg |
EACH TABLET CONTAINS
CLARITHROMYCIN 250,0 mg |
A380630 |
A38/20.1.1/0630 |
2005/07/29 |
Registered
|
info |
| XIXIA PHARMACEUTICALS (PTY) LTD |
XIXIA-CLARITHROMYCIN 500 mg |
EACH TABLET CONTAINS
CLARITHROMYCIN 500,0 mg |
A380631 |
A38/20.1.1/0631 |
2005/07/29 |
Registered
|
info |
| XIXIA PHARMACEUTICALS (PTY) LTD |
XIXIPRIL 1,25 |
EACH CAPSULE CONTAINS
RAMIPRIL 1,25 |
A380514 |
A38/7.1.3/0514 |
2005/11/25 |
Registered
|
info |
| XIXIA PHARMACEUTICALS (PTY) LTD |
XIXIPRIL 2,5 |
EACH CAPSULE CONTAINS
RAMIPRIL 2,5 mg |
A380515 |
A38/7.1.3/0515 |
2005/11/25 |
Registered
|
info |
| XIXIA PHARMACEUTICALS (PTY) LTD |
XIXIPRIL 5 |
EACH CAPSULE CONTAINS
RAMIPRIL 5,0 mg |
A380516 |
A38/7.1.3/0516 |
2005/11/25 |
Registered
|
info |
| XIXIA PHARMACEUTICALS (PTY) LTD |
XIXIPRIL 10 |
EACH CAPSULE CONTAINS
RAMIPRIL 10,0 mg |
A380517 |
A38/7.1.3/0517 |
2005/11/25 |
Registered
|
info |
| XIXIA PHARMACEUTICALS (PTY) LTD |
XIXIA GLIMEPIRIDE 1 mg |
EACH TABLET CONTAINS
GLIMEPIRIDE 1,0 mg |
410700 |
41/21.2/0700 |
2008/10/10 |
#N/A
|
info |
| XIXIA PHARMACEUTICALS (PTY) LTD |
XIXIA GLIMEPIRIDE 2 mg |
EACH TABLET CONTAINS
GLIMEPIRIDE 2,0 mg |
410701 |
41/21.2/0701 |
2008/10/10 |
#N/A
|
info |
| XIXIA PHARMACEUTICALS (PTY) LTD |
XIXIA GLIMEPIRIDE 4 mg |
EACH TABLET CONTAINS
GLIMEPIRIDE 4,0 mg |
410702 |
41/21.2/0702 |
2008/10/10 |
#N/A
|
info |
| XIXIA PHARMACEUTICALS (PTY) LTD |
XIXIA ESCITALOPRAM 5 |
EACH TABLET CONTAINS
ESCITALOPRAM 5,0 mg |
420137 |
42/1.2/0137 |
2009/09/10 |
#N/A
|
info |
| XIXIA PHARMACEUTICALS (PTY) LTD |
XIXIA ESCITALOPRAM 10 |
EACH TABLET CONTAINS
ESCITALOPRAM 10,0 mg |
420138 |
42/1.2/0138 |
2009/09/10 |
#N/A
|
info |
| XIXIA PHARMACEUTICALS (PTY) LTD |
XIXIA ESCITALOPRAM 15 |
EACH TABLET CONTAINS
ESCITALOPRAM 15,0 mg |
420139 |
42/1.2/0139 |
2009/09/10 |
#N/A
|
info |
| XIXIA PHARMACEUTICALS (PTY) LTD |
XIXIA ESCITALOPRAM 20 |
EACH TABLET CONTAINS
ESCITALOPRAM 20,0 mg |
420140 |
42/1.2/0140 |
2009/09/10 |
#N/A
|
info |
| Zydus Healthcare (Pty) Ltd |
XET 20 |
EACH TABLET CONTAINS
PAROXETINE HYDROCHLORIDE EQUIVALENT TO PAROXETINE 20,0 mg |
A390216 |
A39/1.2/0216 |
2005/11/25 |
Registered
|
info |
| Aurogen South Africa (Pty) Ltd |
XAFTRID |
PLERIXAFOR |
550213 |
55/32.2/0213 |
2022/10/18 |
Registrered
|
info |
| Strides Pharma (SA) (Pty) Ltd |
XINITY 5 |
Each film-coated tablet contains SOLIFENACIN SUCCINATE 5,0 mg |
490132 |
49/5.4/0132 |
2022/12/07 |
Registered
|
info |
| Strides Pharma (SA) (Pty) Ltd |
XINITY 10 |
Each film-coated tablet contains SOLIFENACIN SUCCINATE 10,0 mg |
490133 |
49/5.4/0133 |
2022/12/07 |
Registered
|
info |
| Ranbaxy (SA) (Pty) Ltd û Centurion |
XOPTOLAT OPHTHALMIC SOLUTION |
Each 1,0 millilitre contains LATANOPROST 50,0 ?g and TIMOLOL MALEATE EQUIVALENT TO TIMOLOL 5,0 mg |
520077 |
52/15.4/0077 |
2022/12/07 |
Registered
|
info |
| Lamar International (Pty) Ltd |
XYLAZE |
Each 1 ml contains XYLOMETAZOLINE HYDROCHLORIDE EQUIVALENT TO XYLOMETAZOLINE 1,0 mg |
510735 |
51/16.1/0735 |
2022/07/19 |
Registered
|
info |
| Trinity Pharma (Pty) Ltd |
XYLEVE SOLUTION |
Each 1,0 ml contains LEVOCETIRIZINE DIHYDROCHLORIDE 0,5 mg |
470884 |
47/5.7.1/0884 |
2022/08/16 |
Registered
|
info |
| Abex Pharmaceutica (Pty) Lt |
XITOLEC SOLUTION |
Each 1,0 ml solution contains LEVOCETIRIZINE DIHYDROCHLORIDE 0,5 mg |
470952 |
47/5.7.1/0952 |
2022/08/23 |
Registered
|
info |
| Unichem SA (Pty) Ltd |
XYLEVE 5 |
Each tablet contains LEVOCETIRIZINE DIHYDROCHLORIDE 5,0 mg |
480744 |
48/5.7.1/0744 |
2022/08/23 |
Registered
|
info |
| Aurobindo Pharma (Pty) Ltd |
XPERGO 5 MG |
Each tablet contains TADALAFIL 5,0 mg |
490994 |
49/7.1.5/0994 |
2022/08/30 |
Registered
|
info |
| Aurobindo Pharma (Pty) Ltd |
XPERGO 20 MG |
Each tablet contains TADALAFIL 20,0 mg |
490995 |
49/7.1.5/0995 |
2022/08/30 |
Registered
|
info |
| Glenmark Pharmaceuticals South Africa (Pty) Ltd |
XILAZ 50 mg/10 ml |
Oxaliplatin |
560776.773 |
56/26/0776.773 |
2022/12/06 |
Registrered
|
info |
| Glenmark Pharmaceuticals South Africa (Pty) Ltd |
XILAZ 100 mg/20 ml |
Oxaliplatin |
560777.774 |
56/26/0777.774 |
2022/12/06 |
Registrered
|
info |
| Glenmark Pharmaceuticals South Africa (Pty) Ltd |
XILAZ 200 mg/40 ml |
Oxaliplatin |
56/26/0778.775 |
56/26/0778.775 |
2022/12/06 |
Registrered
|
info |
| 3M South Africa (Pty) Ltd |
XYLESTESIN-A |
Each 1,0 ml Solution Contains: Adrenaline Hydrochloride equivalent to Adrenaline 0,0125 mg, Lidocaine Hydrochloride 20,0 mg |
U0104 |
U/4/104 |
1990/06/05 |
Registrered
|
info |
